Multiple Sclerosis
7 competing products in clinical development for Multiple Sclerosis.
Pipeline by Phase
Phase 11
Phase 23
Phase 31
Approved2
All Products (7)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Mirabegron + Placebo | Astellas Pharma | Approved | Completed | 43 |
| Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + Placebo | Astellas Pharma | Approved | Completed | 43 |
| Duloxetine Hydrochloride (HCI) + Placebo | Eli Lilly | Phase 3 | Completed | 40 |
| ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placebo | Ono Pharmaceutical | Phase 2 | Completed | 35 |
| CS-0777 tablets + CS-0777 tablets + CS-0777 tablets | Daiichi Sankyo | Phase 1 | Completed | 29 |
| ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 | Ono Pharmaceutical | Phase 2 | Terminated | 27 |
| mRNA-1195 | Moderna | Phase 2 | Recruiting | 0 |